These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Therapeutic targeting of splicing in cancer. Lee SC; Abdel-Wahab O Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132 [TBL] [Abstract][Full Text] [Related]
27. How mRNA is misspliced in acute myelogenous leukemia (AML)? Mohamed AM; Thénoz M; Solly F; Balsat M; Mortreux F; Wattel E Oncotarget; 2014 Oct; 5(20):9534-45. PubMed ID: 25375204 [TBL] [Abstract][Full Text] [Related]
28. Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia. Yang F; Anekpuritanang T; Press RD Mol Diagn Ther; 2020 Feb; 24(1):1-13. PubMed ID: 31848884 [TBL] [Abstract][Full Text] [Related]
29. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia. Shi M; Xu G BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922 [TBL] [Abstract][Full Text] [Related]
30. Aberrant splicing and drug resistance in AML. de Necochea-Campion R; Shouse GP; Zhou Q; Mirshahidi S; Chen CS J Hematol Oncol; 2016 Sep; 9(1):85. PubMed ID: 27613060 [TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361 [TBL] [Abstract][Full Text] [Related]
32. Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells. van der Werf I; Mondala PK; Steel SK; Balaian L; Ladel L; Mason CN; Diep RH; Pham J; Cloos J; Kaspers GJL; Chan WC; Mark A; La Clair JJ; Wentworth P; Fisch KM; Crews LA; Whisenant TC; Burkart MD; Donohoe ME; Jamieson CHM Cell Rep Med; 2023 Mar; 4(3):100962. PubMed ID: 36889320 [TBL] [Abstract][Full Text] [Related]
33. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma. Xing L; Zhang X; Tong D DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877 [TBL] [Abstract][Full Text] [Related]
34. A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers. Wang D; Quesnel-Vallieres M; Jewell S; Elzubeir M; Lynch K; Thomas-Tikhonenko A; Barash Y Nat Commun; 2023 Jan; 14(1):63. PubMed ID: 36599821 [TBL] [Abstract][Full Text] [Related]
35. Splicing factor gene mutations in hematologic malignancies. Saez B; Walter MJ; Graubert TA Blood; 2017 Mar; 129(10):1260-1269. PubMed ID: 27940478 [TBL] [Abstract][Full Text] [Related]
36. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Pellagatti A; Armstrong RN; Steeples V; Sharma E; Repapi E; Singh S; Sanchi A; Radujkovic A; Horn P; Dolatshad H; Roy S; Broxholme J; Lockstone H; Taylor S; Giagounidis A; Vyas P; Schuh A; Hamblin A; Papaemmanuil E; Killick S; Malcovati L; Hennrich ML; Gavin AC; Ho AD; Luft T; Hellström-Lindberg E; Cazzola M; Smith CWJ; Smith S; Boultwood J Blood; 2018 Sep; 132(12):1225-1240. PubMed ID: 29930011 [No Abstract] [Full Text] [Related]
37. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003 [TBL] [Abstract][Full Text] [Related]
38. Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms. Chao MM; Thomay K; Goehring G; Wlodarski M; Pastor V; Schlegelberger B; Schindler D; Kratz CP; Niemeyer C Klin Padiatr; 2017 Nov; 229(6):329-334. PubMed ID: 29132164 [TBL] [Abstract][Full Text] [Related]
39. The U1 spliceosomal RNA is recurrently mutated in multiple cancers. Shuai S; Suzuki H; Diaz-Navarro A; Nadeu F; Kumar SA; Gutierrez-Fernandez A; Delgado J; Pinyol M; López-Otín C; Puente XS; Taylor MD; Campo E; Stein LD Nature; 2019 Oct; 574(7780):712-716. PubMed ID: 31597163 [TBL] [Abstract][Full Text] [Related]
40. A Genetic Screen for Pre-mRNA Splicing Mutants of Kanno T; Lin WD; Fu JL; Chang CL; Matzke AJM; Matzke M Genetics; 2017 Dec; 207(4):1347-1359. PubMed ID: 28971960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]